⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RLMD News
Relmada Therapeutics, Inc. Common Stock
Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate Indications
globenewswire.com
RLMD
Aronora Appoints Industry Leaders to Drive Next Phase of Growth
globenewswire.com
GILD
EXAS
RLMD
Relmada Therapeutics Announces Presentation of NDV-01 Phase 2 Data at the Society for Urologic Oncology
globenewswire.com
RLMD
Relmada Therapeutics Reports Third Quarter 2025 Financial Results and Provides Key Clinical, Regulatory, and Corporate Updates
globenewswire.com
RLMD
Sidoti Events, LLC's Virtual September Small-Cap Conference
accessnewswire.com
CMCO
UXIN
MPTI
PKOH
CRAI
HITI
ONIT
IDT
VNCE
KINS
BHE
GCT
MAGN
DAKT
TNC
NMTC
HVT
PLUS
RELL
STRR
VREX
GAIA
HIPO
COE
ABM
ASTE
EVI
HWKN
IIIN
KELYA
KFRC
LXFR
MTUS
UIS
VPG
DYAI
FSTR
RLMD
PLCE
ROCK
SGC
HURN
LGL
PSTL
GLDD
KGEI
III
GIC
OPRT
MEI
ABL
SBC
FMAO
FBRT
PBH
FFAI
BZH
CTS
IDCC
LZB
MATV
OSPN
SLVM
VPG